Cefepime Hydrochloride Monohydrate
Records for this ingredient, by country (identity only).
ATC J01DE01 · 1 markets · 9 records
AU 9 records · 5 shown of 5
- 2,378 mg per mL / per unit basis not statedinjectionCEFEPIME DEMOGEN cefepime (as hydrochloride monohydrate) 2 g powder for injection vialCefepime-AFT cefepime hydrochloride monohydrate equivalent to cefepime 1 g, powder for injection, vial
- 1,189 mg per mL / per unit basis not statedinjectionCEFEPIME DEMOGEN cefepime (as hydrochloride monohydrate) 2 g powder for injection vialCefepime-AFT cefepime hydrochloride monohydrate equivalent to cefepime 1 g, powder for injection, vial
- 2,378.5 mg per mL / per unit basis not statedinjectionCEFEPIME KABI cefepime (as hydrochloride) 2 g powder for injection vial
- 1,189.2 mg per mL / per unit basis not statedinjectionCEFEPIME KABI cefepime (as hydrochloride) 2 g powder for injection vial
- 595 mg per mL / per unit basis not statedinjectionCefepime-AFT cefepime hydrochloride monohydrate equivalent to cefepime 1 g, powder for injection, vial
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Cefepime Kabi ×2Cefepime-AFT ×1
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.